CurifyLabs is a healthtech company building solutions for automated compounding of personalized medicines in pharmacies and hospitals. Its Compounding System Solution is an automated platform for non-sterile compounding that combines GMP-manufactured excipient bases, compounding robotics inspired by 3D printing, integrated in-process quality control, software, and a formulation library.
Investment Rounds
Capital activity and funding progression
Industries
Frequently Asked Questions
Where is CurifyLabs located?
CurifyLabs is located in Helsinki, Finland.
What industries does CurifyLabs operate in?
CurifyLabs operates in the following industries: Healthtech, Pharmaceutical Manufacturing.
When was CurifyLabs founded?
CurifyLabs was founded on 2026-07-06.
How much total funding has CurifyLabs raised?
CurifyLabs has raised a total of $14,000,000.
Who are the investors in CurifyLabs?
The investors in CurifyLabs are: Sandwater, HealthCap, Tesi (Finnish Industry Investment Ltd), Lifeline Ventures.
What is CurifyLabs and what does it do?
CurifyLabs is a healthtech company that develops automated solutions for the pharmaceutical compounding of personalized medicines in pharmacies and hospitals. Its technology modernizes traditionally manual and labor-intensive compounding processes by integrating 3D printing, proprietary software, and GMP-manufactured excipient bases to create precise, safer, and more efficient patient-specific therapies.
What is the CurifyLabs Compounding System Solution (CSS)?
The Compounding System Solution (CSS) is an integrated, modular platform that automates non-sterile compounding. It combines specialized software, GMP-compliant excipient bases (pharma inks), robotics inspired by 3D printing, and integrated quality control to allow pharmacists to produce tailored dosage forms like tablets, films, troches, and liquids with full traceability and digital batch records.
How does 3D printing improve the compounding process at CurifyLabs?
3D printing technology enables the automation of compounding, significantly increasing speed and precision compared to manual methods. It allows for the creation of individualized dosages, shapes, and forms tailored to specific patient needs—such as children, the elderly, or cancer patients—while reducing human error, minimizing drug waste, and ensuring standardized quality and safety.
Is CurifyLabs a pharmaceutical company or a technology provider?
CurifyLabs is a healthtech company. While it operates within the pharmaceutical ecosystem and develops GMP-manufactured materials (excipient bases/inks), its primary focus is on providing the technology, software, and hardware platform that enables pharmacies and hospitals to modernize and automate their own compounding operations.
Who founded CurifyLabs and where is it located?
CurifyLabs was founded in 2021 by CEO Charlotta Topelius and CTO Professor Niklas Sandler Topelius. The company is headquartered in Helsinki, Finland, and maintains operations and offices in Europe and the United States.